Botox and dermal fillers built your medical spa business—but relying on injectables alone creates dangerous vulnerability in an increasingly competitive market. As new med spas open seemingly every month, prices compress, client acquisition costs rise, and pure injectable practices find themselves trapped in a race to the bottom. Meanwhile, sophisticated operators are building diversified service portfolios generating multiple revenue streams, attracting broader client demographics, and creating sustainable competitive advantages that command premium valuations. Whether you’re preparing for an eventual exit or building long-term enterprise value, strategic service line diversification isn’t optional—it’s essential for survival and growth in 2026’s evolving aesthetics landscape. This comprehensive guide reveals how leading medical spas are expanding beyond traditional injectables to create resilient, highly profitable businesses positioned for sustained success.